Floatz logo

Rezatapopt

Advanced Solid Tumor

PMV Pharmaceuticals, IncPhase 1/2Active
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
59/ 100

Competitive context

1411 Active assets in the Advanced Solid Tumor cohort.

Asset / SponsorPhaseRating
Nabiximols
Jazz Pharmaceuticals
Phase 3BBB
Inno-206
M.D. Anderson Cancer Center
Phase 2BB
Vitamin B6
M.D. Anderson Cancer Center
Phase 4BB
Rivoceranib
Jiangsu HengRui Medicine Co., Ltd.
Phase 4BB
Desflurane
Peter MacCallum Cancer Centre, Australia
Phase 4BB

View all 50 →

Same molecule, other indications

Rezatapopt is also rated in:

HER2 positive breast carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
neoplasmDormant
CCC
Indicative ·
48 / 100
View asset →
hormone receptor-positive breast cancerDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →